Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations: Table 1-Reference-Cited by-同舟云学术

Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations: Table 1

Published:2015-05-12 Issue:4 Volume:1 Page:232-244
ISSN:2055-6837
Container-title:European Heart Journal - Cardiovascular Pharmacotherapy
language:en
Short-container-title:Eur Heart J Cardiovasc Pharmacother

Author:

Jukema J. Wouter,Lettino Maddalena,Widimský Petr,Danchin Nicolas,Bardaji Alfredo,Barrabes Jose A.,Cequier Angel,Claeys Marc J.,De Luca Leonardo,Dörler Jakob,Erlinge David,Erne Paul,Goldstein Patrick,Koul Sasha M.,Lemesle Gilles,Lüscher Thomas F.,Matter Christian M.,Montalescot Gilles,Radovanovic Dragana,Lopez-Sendón Jose,Tousek Petr,Weidinger Franz,Weston Clive F.M.,Zaman Azfar,Zeymer Uwe

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/ehjcvp/article-pdf/1/4/232/1131412/pvv024.pdf

Reference84 articles.

1. Heart Disease and Stroke Statistics—2015 Update

2. World Health Organization. The top 10 causes of death. Fact sheet N° 310. Updated May 2014. Internet: http://www.who.int/mediacentre/factsheets/fs310/en/ (12 March 2015).

3. Third universal definition of myocardial infarction

4. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

5. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient characteristics, treatment strategy, outcomes, and hospital costs of acute coronary syndrome: 3 years of data from a large high-volume centre in Central Europe;European Heart Journal Supplements;2022-03-30

2. The Role of Clopidogrel in 2020: A Reappraisal;Cardiovascular Therapeutics;2020-03-27

3. Antiplatelet treatment in coronary syndrome;European Heart Journal - Cardiovascular Pharmacotherapy;2020-03-13

4. Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries;European Heart Journal - Cardiovascular Pharmacotherapy;2020-01-22

5. Did Prasugrel and Ticagrelor Offer the Same Benefit in Patients with Acute Coronary Syndromes after Percutaneous Coronary Interventions Compared to Clopidogrel? Insights from Randomized Clinical Trials, Registries and Meta-analysis;Current Pharmaceutical Design;2018-04-24